PAB huge announcement: New United States patent granted for Patrys' deoxymab assets
Further United States patent granted for PAB deoxymab assets
A patent covering the use of PAB novel deoxymabs (including both PAT-DX1 and PAT-DX3) in combination with radiosensitising agent(s) that damage DNA or inhibit DNA repair
